ToMORROW prescription intramammary antibiotic gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.

• ToMORROW has been an effective prolonged therapy treatment for more than 25 years.
• ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by Streptococcus agalactiae and  Staphylococcus aureus,  including penicillin-resistant strains.
• ToMORROW is formulated with cephapirin benzathine to provide broad-spectrum and long-acting therapy that dry cows need.

TOP REASONS TO USE ToMORROW^® (cephapirin benzathine intramammary infusion)

1. Targets the most common bacteria at dry-off
   ToMORROW prescription intramammary antibiotic effectively targets and controls Gram-positive organisms, which represent 94% of infections that occur during dry-off.¹

    

2. Equally effective as the competition
   In a head-to-head study, ToMORROW antibiotic was found to be equally as effective as Spectramast^® DC (ceftiofur hydrochloride) and Quartermaster^® (penicillin-dihydrostreptomycin in oil) in bacteriological cure.¹

    

3. Shorter milk and slaughter withhold
   Milk withhold: 72 hours versus 96 hours post calving for Quartermaster, which means you can put your cows back into production sooner.
   Slaughter withhold: 42 days versus 60 days after the last infusion + 96 hours after calving for Quartermaster allows you to market 22 days sooner.

    

4. Opti-Sert^® reduces new infections
   The Opti-Sert^® tip reduces new mastitis infections by up to 50%,² and makes partial insertion easier.

Presentations

• Pail containing 144 x 10-mL syringes and 144 convenient single-use alcohol pads.
• Cartons containing 12 x 10-mL syringes with 12 convenient single-use alcohol pads.

Partial insertion reduces new infections

• With the Opti-Sert^® applicator tip, partial insertion reduces the incidence of new infections during the dry period.²
• Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent.²

Dosage Information

• Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.

Product Inserts & Labels

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Safety Information

ToMORROW should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.
 

Residue Warnings

• For use in dry cows only.
• Not to be used within 30 days of calving.
• Milk from treated cows must not be used for food during the first 72 hours after calving.
• Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion.